Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

 

Insights from 2024 ESMO Sarcoma and Rare Cancers Congress
R

Lurbinectedin + Irinotecan in Pre-Treated Gastroenteropancreatic Neuroendocrine Carcinomas

By Insights from 2024 ESMO Sarcoma and Rare Cancers Congress FEATURING Rocio Garcia-Carbonero
By Insights from 2024 ESMO Sarcoma and Rare Cancers Congress FEATURING Rocio Garcia-Carbonero
97 views
April 15, 2024
Comments 0
Login to view comments. Click here to Login
Videos
07:00

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Ripreti…

Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

J. Blay

192 views
09:59

Lurbinectedin + Irinotecan in Pre-Treated Gastroenteropancreatic Neu…

Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

R. Garcia-Carbonero

97 views